Mortality after surgery for benign prostate hyperplasia: a nationwide cohort study - Takeaways - MDSpire

Mortality after surgery for benign prostate hyperplasia: a nationwide cohort study

  • By

  • Alisa Salmivalli

  • Otto Ettala

  • Peter J. Boström

  • Ville Kytö

  • April 16, 2022

  • 0 min

Share

  • 1

    Surgical treatment for benign prostate hyperplasia (BPH) remains necessary despite advancements in medical therapy.

  • 2

    Mortality rates after endourologic surgery for BPH vary, with TURP showing a 1.16% mortality rate compared to 0.59% for laser vaporization.

  • 3

    The study analyzed data from 39,320 patients who underwent BPH procedures in Finland between 2004 and 2014.

  • 4

    Most patients in the study had a Charlson comorbidity index score of 0, indicating low comorbidity burden.

  • 5

    The findings suggest that age and comorbidities should be carefully considered when selecting surgical techniques for BPH.

Original Source(s)

Mortality after surgery for benign prostate hyperplasia: a nationwide cohort study

  • by Alisa Salmivalli, Otto Ettala, Peter J. Boström, Ville Kytö

  • April 16, 2022

Related Content

A feasibility study on utility of a new digital disposable semirigid nephroscope for Suction mini-percutaneous nephrolithotripsy

Effectiveness and safety of ultra-slow full power shockwave lithotripsy compared to mini–percutaneous nephrolithotomy and retrograde intrarenal surgery for treatment of lower calyceal stone between 1 and 2 cm with high attenuation value

Suction mini-percutaneous nephrolithotomy versus standard percutaneous nephrolithotomy for the management of 2–4 cm kidney stones: study protocol for an international, multicenter, parallel-group, noninferiority, randomized controlled trial